From Harvard to Vienna: Epigenetics expert Davide Seruggia joins  St. Anna CCRI as Principal Investigator

From Harvard to Vienna: Epigenetics expert Davide Seruggia joins St. Anna CCRI as Principal Investigator

(27.01.2021) Davide Seruggia, PhD, ERC Starting Grant awardee, leaves Harvard School of Medicine to start his own research group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI). The young scientist is looking forward to investigate epigenetic mechanisms of gene regulation in childhood leukemia to discover truly innovative treatment…

New approach explains how protein complexes regulate cancer genes

New approach explains how protein complexes regulate cancer genes

(Vienna, 22.02.2021): While NUP98-fusion proteins have been shown to cause leukaemia, the molecular mechanisms have so far been unknown. In a recently published study in Nature Structural & Molecular Biology led by Vetmeduni Vienna, with the participation of St. Anna Children's Cancer Research Institute and others, researchers have now been…

CCRI Christian-Doppler Lab wins BOKU Invention of the Year 2020 Award

CCRI Christian-Doppler Lab wins BOKU Invention of the Year 2020 Award

(Vienna, 18.12.2020) Each year, the University of Natural Resources and Life Sciences (BOKU), Vienna awards the most outstanding invention. In 2020, the prize went to our co-inventors from the external module of CCRI´s Christian-Doppler Laboratory for Next Generation CAR T Cells, DI Michael Traxlmayr, PhD, and Charlotte Zajc, PhD, with…

Video: Early cancer diagnosis seems crucial in children with immune defect

Video: Early cancer diagnosis seems crucial in children with immune defect

(Vienna, 03.12.2020) CD27/CD70 deficiencies can lead to cancer in small children: “If diagnosed at an early stage, the majority of these patients are responsive to the hematopoietic stem cell treatment”, says Co-first author Sevgi Köstel Bal, MD, Phd, St. Anna Children's Cancer Research Institute (CCRI)’s, in a video statement on…

Cancer in children with rare inborn immune defect: High cure rate if treated early

Cancer in children with rare inborn immune defect: High cure rate if treated early

(Vienna, 03.12.2020) New research data highlight a marked predisposition to lymphoma, a type of cancer, in children harboring specific gene mutations. A significant fraction of these rare mutations also cause inborn immune defects associated with recurrent infections. Collaborating closely with leading centers across the world, researchers investigated patients bearing recently…

Selected for funding:  Training a new generation of childhood cancer scientists

Selected for funding: Training a new generation of childhood cancer scientists

(Vienna, 24.11.2020) St. Anna Children’s Cancer Research Institute is part of a European Marie Sklodowska-Curie Actions Innovative Training Network ITN. Being awarded with this grant, Prof. Heinrich Kovar, PhD, is looking forward to train an international PhD student within the VAGABOND program. The successful candidate will investigate druggable molecular pathways…